Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD
This invention relates to the treatment of bleeding disorders, including congenital coagulation disorders, acquired coagulation disorders, and trauma induced hemorrhagic conditions. In particular, this invention relates to the use of non-anticoagulant sulfated polysaccharides (NASP)
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD
This invention relates to the treatment of bleeding disorders, including congenital coagulation disorders, acquired coagulation disorders, and trauma induced hemorrhagic conditions. In particular, this invention relates to the use of non-anticoagulant sulfated polysaccharides (NASP)
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD
This invention relates to the treatment of bleeding disorders, including congenital coagulation disorders, acquired coagulation disorders, and trauma induced hemorrhagic conditions. In particular, this invention relates to the use of non-anticoagulant sulfated polysaccharides (NASP)
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD
This invention relates to the treatment of bleeding disorders, including congenital coagulation disorders, acquired coagulation disorders, and trauma induced hemorrhagic conditions. In particular, this invention relates to the use of non-anticoagulant sulfated polysaccharides (NASP)
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present application is filed under 35 U.S.C. .sctn.371 as a U.S. national phase application of PCT application no. PCT/FR2005/001378, which was filed Jun. 6, 2005. The aforementioned PCT application claimed benefit of priority of French Patent Application No. 0406405, which was filed Jun. 14,
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD
This invention relates to hemostatic compositions and methods employing the same, and more particularly to hemostatic compositions useful for controlling bleeding at active bleeding wound sites.
BACKGROUND
Wounds are generally classified as acute or chronic in accordance with their
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
Conventional bone wax is a sterile beeswax preparation that can optionally include softening agents in combination with the beeswax to improve pliability. Conventional bone wax is commonly used as a hemostatic material to control local bleeding.
While conventional
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This application is the US national phase of international application PCT/IB2004/004128 filed 15 Dec. 2004 which designated the U.S. and claims benefit of IT MI2003A002498 filed 17 Dec. 2003, the entire contents of each of which are hereby incorporated by reference.
OBJECT OF THE INVENTION
The
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
INTRODUCTION
Bleeding is one of the most serious and significant manifestations of disease, and may occur from a local site or be systemic. Localized bleeding may be associated with lesions and may be further complicated by a defective haemostatic mechanism. Blood clotting is inadequate in bleeding
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
INTRODUCTION
Bleeding is one of the most serious and significant manifestations of disease, and may occur from a local site or be systemic. Localized bleeding may be associated with lesions and may be further complicated by a defective haemostatic mechanism. Blood clotting is inadequate in bleeding
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD
The invention relates generally to methods and compositions for achieving hemostasis and blood coagulation, and more specifically relates to methods and compositions for achieving hemostasis and blood coagulation during surgical procedures.
BACKGROUND
Bleeding and blood loss are problems that
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to fluid resuscitation. Such resuscitation is required or is desirable in treatment of burn injury, lung injury caused by inhalation of hot and/or toxic substances, such as smoke derived from combustion, and hemorrhagic shock.
BACKGROUND OF THE
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD
The present invention relates to a novel composition for inhibiting vascular intimal hyperplasia.
BACKGROUND ART
Percutaneous transluminal coronary angioplasty (hereinafter referred to as "PTCA") is a therapeutic technique recently developed for nonsurgical treatment of coronary
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The invention relates to a new anti-thromboticum based on a mixture of oligo- and polysaccharides and to methods for preparation thereof. The invention also relates to pharmaceutical compositions which include the said mixture.
It is known that certain mucopolysaccharides influence the coagulation
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to a styptic composition, its preparation method and application, specifically Jinshuye styptic composition made by extraction and purification of a single plant for treating thrombocytopenia and regulating immunity, its preparation method and
Database tanaman obat terlengkap yang didukung oleh sains
Bekerja dalam 55 bahasa
Pengobatan herbal didukung oleh sains
Pengenalan herbal melalui gambar
Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
Baca publikasi ilmiah yang terkait dengan pencarian Anda
Cari tanaman obat berdasarkan efeknya
Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten
Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya. * Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan